OUR PRODUCTS
POPULATION HEALTH ANALYSIS (PHA)
Incorporating a plan sponsor's complete set of non-personally identifiable transactional drug claims data with Cubic Health's proprietary SFC Therapeutic Classification System™, the Population Health Analysis (PHA) provides a detailed demographic profile of the group and comprehensive therapeutic breakdowns including the cost, utilization and prevalence of specific disease states within the plan member population. Advanced reporting options include measuring plan members' adherence with therapy within key disease states such as depression, and measuring the overall impact of co-morbid conditions.
The PHA is ideally suited for:
- Plan sponsors who have completed a Plan Performance Review™, understand that their drug plan is being administered well according to its current design, yet need to further investigate their cost increases and utilization pressures from demographic and therapeutic perspectives to:
- Understand and predict future cost pressures and liabilities, and
- Fully understand their plan's experience including the cost, utilization and prevalence of specific disease states, as a necessary part of a strategic process towards selecting a new plan design and/or formulary.
- Plan sponsors requiring comprehensive demographic and therapeutic breakdowns to determine which key disease states to best target with workplace wellness initiatives and the baseline metrics necessary to measure return on investment.
